Produkty 1173-26-8

CAS 1173-26-8 występuje w naszej ofercie pod nazwami: Corticosterone 21-Acetate, >95% (HPLC), Corticosterone 21-acetate, 2-((8S,9s,10r,11s,13s,14s,17s)-11-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate. Oferty producentów: TRC, Biosynth, Chemat. Dostępne opakowania: 100mg, 50mg, 25mg, 250mg, 1g, 5g.

Corticosterone 21-Acetate, >95% (HPLC)
TRC
  • opakowanie: 100mg
  • Warianty: 1
Zobacz produkt
Corticosterone 21-acetate
Biosynth
  • opakowanie: 50mg, 25mg
  • Warianty: 2
Zobacz produkt
2-((8S,9s,10r,11s,13s,14s,17s)-11-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
Chemat
  • opakowanie: 50mg, 250mg, 1g, 5g
  • Warianty: 4
od 136,40
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate (CAS 1173-26-8) to związek chemiczny o wzorze sumarycznym C23H32O5 i masie molowej 388.5 g/mol. Nazwa systematyczna IUPAC: [2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate. InChIKey: WKQCPUMQBMFPLC-ZWFCQKKLSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H32O5
Masa molowa388.5 g/mol
Nazwa IUPAC[2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
InChIKeyWKQCPUMQBMFPLC-ZWFCQKKLSA-N
SMILESCC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Corticosterone acetate, Corticosterone 21-acetate, 11beta,21-Dihydroxypregn-4-ene-3,20-dione 21-acetate, Cort A, Pregn-4-ene-3,20-dione, 21-(acetyloxy)-11-hydroxy-, (11beta)-, Pregn-4-ene-3,20-dione, 21-(acetyloxy)-11-hydroxy-, (11.beta.)-, Pregn-4-ene-3,20-dione, 21-(acetyloxy)-11-hydroxy-, (11b)-, 21-O-Acetyl-corticosterone, 11.beta.,20-dione acetate, 11-beta,21-Dihydroxypregn-4-ene-3,20-dione acetate
Izomery (ten sam wzór sumaryczny)
[(1S,3S,7S,8S,8aR)-3-hydroxy-7-methyl-8-[2-[(2R)-6-oxo-2,3-dihydropyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate C23H32O5
(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid C23H32O5
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxo-5-phenylpentyl)cyclopentyl]hept-5-enoic acid C23H32O5
(Z)-3,3,4,4-tetradeuterio-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid C23H32O5
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid C23H32O5
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid C23H32O5
[2-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H32O5
[(6S,9R,13R)-6-hydroxy-13-methyl-16-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-17-en-6-yl]methyl acetate C23H32O5
[(6R,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H32O5
[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H32O5
[(2R,8R,9S,10R,13S,14S,17S)-2-acetyloxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C23H32O5
[(2R,8R,9S,10R,13S,14S,17R)-2-acetyloxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C23H32O5